Oxytocin-induced prostaglandin E2 (PGE2) synthesis is regulated by progesterone via oxytocinase in Ishikawa cells.

Cell-surface oxytocinase inactivates oxytocin and regulates oxytocin stimulation. We reported that oxytocinase in human endometrial epithelial cells was secreted from the cell membrane in the mid-secretory phase and disappeared from the cell surface. On the other hand, the production in human endometrium of prostaglandins, which play important roles in the reproductive process, has been reported to be upregulated by oxytocin. We investigated whether progesterone affects cell-surface oxytocinase and oxytocin-induced prostaglandin E2 (PGE2) production in vitro. Progesterone induced secretion of oxytocinase into the culture medium, which resulted in a decrease in cell-surface oxytocinase. Production of PGE2 was increased slightly by oxytocin without progesterone, and significantly with progesterone. The inhibition of oxytocinase activity by amastatin had a similar effect to the loss of cell-surface oxytocinase caused by progesterone. It is therefore likely that the cell-surface oxytocinase of endometrial epithelial cells modified by progesterone plays an important role in the function of the human endometrium through PGE2.     

Novel approaches to molecular recognition using porphyrins

Studies of molecular recognition using designed and synthesised molecules provide valuable information on the principle and possible applications of artificial functional molecules. Porphyrin-based receptors have been used to elucidate haem-protein interactions and the basic mechanism of multi-point recognition.     

Erect leaves caused by brassinosteroid deficiency increase biomass production and grain yield in rice

New cultivars with very erect leaves, which increase light capture for photosynthesis and nitrogen storage for grain filling, may have increased grain yields. Here we show that the erect leaf phenotype of a rice brassinosteroid-deficient mutant, osdwarf4-1, is associated with enhanced grain yields under conditions of dense planting, even without extra fertilizer. Molecular and biochemical studies reveal that two different cytochrome P450s, CYP90B2/OsDWARF4 and CYP724B1/D11, function redundantly in C-22 hydroxylation, the rate-limiting step of brassinosteroid biosynthesis. Therefore, despite the central role of brassinosteroids in plant growth and development, mutation of OsDWARF4 alone causes only limited defects in brassinosteroid biosynthesis and plant morphology. These results suggest that regulated genetic modulation of brassinosteroid biosynthesis can improve crops without the negative environmental effects of fertilizers.     

Henneguya cartilaginis n. sp. (Myxozoa: Myxosporea) in the head cartilage of masu salmon Oncorhynchus masou masou

Henneguya cartilaginis n. sp. (Myxozoa: Myxosporea) is described from wild masu salmon Oncorhynchus masou masou in Hokkaido, Japan. H. cartilaginis n. sp. produced white cysts, up to 3mm in size, in the head of masu salmon. Infected fish exhibited cranial protrusion due to the cysts. Spores (11.4 × 8.6μm) of H. cartilaginis n. sp. were egg-shaped with the posterior end more pointed and possessed two caudal appendages (34.2μm average length). Histological observations revealed that large plasmodia possessing fine fibrous pseudopodia on the surface developed in the head cartilage. H. cartilaginis n. sp. resembles H. cerebralis, which was described from the cranial cartilage of Kosogol grayling Thymallus nigrescens in Mongolia. However, they were distinguishable by spore morphology. Molecular analysis of the 18S rDNA sequences indicated that H. cartilaginis n. sp. was most closely related to Henneguya zschokkei, H. nuesslini and H. salminicola of salmonid fish, with genetic similarities of 95.3%, 95.1% and 93.9%, respectively. Based on these differences in spore morphology, molecular data, the site of infection and geographical distribution, the present species is considered to be a new species.     

Changes in placental dipeptidyl peptidase IV in preeclampsia with intrauterine growth restriction.

The purpose of this study was to examine alterations in placental expression of dipeptidyl peptidase IV (DPPIV). The localization of DPPIV was compared in control and preeclamptic placentas. Enzyme activity, mRNA, and protein expression were also measured. In term placentas, DPPIV was expressed preferentially in the fetal vascular endothelial cells within stem villi and only weakly in the villous stromal cells. DPPIV activity in control placentas showed no remarkable changes throughout gestation. Levels of activity in samples from normotensive control cases and women having preeclampsia with or without intrauterine growth restriction were 11.8 +/- 2.1, 13.4 +/- 1.1, and 15.3 +/- 0.62 pmol pNA/min/mg protein, respectively. The preeclamptic placentas with intrauterine growth restriction thus showed significantly higher levels of activity than the controls (p < 0.05). We propose that placental DPPIV influences fetal metabolism via the degradation of fetoplacental circulating bioactive peptides, including incretins, resulting in the regulation of fetal growth.